SHOT.NASDAQSafety Shot, INC

S-1/A: Bonk, Inc. Amends S-1 Filing, Details Offering Costs

Sentiment:

Registration Statement Amendment


Bonk, Inc. filed an amendment to its S-1 registration statement, primarily to include an auditor's consent and detail estimated offering expenses.

Delay expectedThe effective date of the registration statement is being delayed until a further amendment is filed or until the SEC determines its effectiveness.
Capital raiseThe registration statement is for the proposed sale of common stock.Estimated costs for the issuance and distribution of this common stock total $113,397.44.The offering is intended to be on a delayed or continuous basis pursuant to Rule 415.

Summary

  • This is Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-292056) for Bonk, Inc. (f/k/a Safety Shot, Inc.).
  • The amendment is an 'exhibit-only filing' to include Exhibit 23.1, which is the Consent of M&K CPAS, PLLC.
  • The prospectus constituting Part I of the Registration Statement has been omitted from this amendment.
  • Estimated costs and expenses for the sale of common stock being registered total $113,397.44.
  • These costs include an SEC registration fee of $897.44, legal fees and expenses of $100,000, accounting fees and expenses of $7,500, and miscellaneous expenses of $5,000.
  • Bonk, Inc. is incorporated under Delaware law and references sections of the General Corporation Law of the State of Delaware (DGCL) regarding director and officer indemnification.
  • The company's bylaws contain provisions allowing for indemnification of persons against liabilities and expenses incurred in connection with service, provided they acted in good faith and in the company's best interest.
  • Separate indemnification agreements have been entered into with the company's directors and certain officers.
  • The company expects to obtain and maintain insurance policies to cover its directors and officers against certain expenses and liabilities.
  • The SEC's opinion is that indemnification for liabilities arising under the Securities Act of 1933 is against public policy and therefore unenforceable.
  • The filing includes a comprehensive list of exhibits, many incorporated by reference from previous SEC filings, covering corporate governance documents, warrants, convertible notes, and various agreements.
  • The company undertakes to file post-effective amendments to include required prospectuses, reflect fundamental changes, and disclose material changes to the plan of distribution, as well as to remove unsold securities at the termination of the offering.

Sentiment

Score: 5

Explanation: This is a neutral, procedural filing. It indicates ongoing compliance and preparation for a potential offering but contains no new substantive financial or operational information to sway sentiment positively or negatively.

Positives

  • The company is actively progressing with its registration statement, indicating ongoing efforts towards a public offering or maintaining compliance for existing offerings.
  • Clear disclosure of estimated offering expenses provides transparency to potential investors and stakeholders.
  • Robust indemnification provisions and plans for Director & Officer (D&O) insurance aim to protect management, which can help attract and retain qualified personnel.

Negatives

  • The SEC's stated opinion that indemnification for liabilities under the Securities Act of 1933 is against public policy could expose directors and officers to personal liability in certain circumstances.
  • This filing is a procedural amendment and does not contain new substantive financial results or operational updates, limiting immediate actionable insights.
  • The omission of the prospectus means that detailed financial and business information is not provided within this specific amendment.

Risks

  • Directors and officers face potential personal liability for Securities Act violations if indemnification is deemed unenforceable by the SEC or courts.
  • The estimated offering costs of $113,397.44 will be borne by the company, impacting its capital resources.
  • Ongoing compliance requirements for a public company, including filing post-effective amendments and reports, represent a continuous administrative burden and associated costs.

Future Outlook

The proposed sale to the public is expected to occur from time to time after the effective date of this registration statement, indicating a continuous or delayed offering. The company undertakes to file post-effective amendments to reflect material changes and include required prospectuses, signaling ongoing compliance and potential future offerings.

Industry Context

This filing is a standard procedural amendment for a company seeking to register securities for public sale. It reflects the ongoing regulatory compliance required for publicly traded companies or those in the process of going public. The detailed indemnification provisions are common in corporate governance to protect executives, though the SEC's stance on Securities Act liabilities is a recurring point of regulatory tension.

Comparison to Industry Standards

  • The estimated offering expenses, particularly legal fees at $100,000, appear within a typical range for an S-1 amendment of this nature, though specific comparisons would require knowing the size and complexity of the underlying offering.
  • The indemnification provisions align with standard Delaware General Corporation Law (DGCL) practices, which are widely adopted by U.S. corporations for director and officer protection.
  • The company's undertakings to file post-effective amendments are standard regulatory requirements for continuous offerings under Rule 415, demonstrating adherence to SEC guidelines.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Indemnification PolicyThe company's bylaws allow for indemnification of persons against liabilities and expenses incurred in connection with service, provided they acted in good faith and in the company's best interest.NAEnhances protection for directors and officers, potentially aiding in attracting and retaining talent, but subject to limitations under Delaware law and SEC public policy.
Indemnification AgreementsSeparate indemnification agreements have been entered into with directors and certain officers to indemnify them against certain liabilities.NAProvides contractual protection beyond bylaws, reinforcing the company's commitment to D&O indemnification.
D&O InsuranceThe company expects to obtain and maintain insurance policies to cover directors and officers against certain expenses and liabilities.NAOffers an additional layer of financial protection for directors and officers, mitigating personal risk.

Legal Proceedings

  • Stipulation of Settlement between the Company and 3i LP dated April 23, 2025.
  • Form of Settlement and Stipulation Agreement between the Company and Silverback Capital Corporation.
  • Amendment to Settlement Agreement and Mutual Release between the Company and Bigger Capital LLC.

Stakeholder Impact

  • Shareholders: Potential dilution from future common stock sales, but also increased transparency and liquidity if the offering proceeds. Indemnification provisions protect directors, which can indirectly benefit shareholders by ensuring stable governance.
  • Directors and Officers: Enhanced protection from liabilities through indemnification and D&O insurance, reducing personal financial risk.
  • Investors: Provides updated regulatory information and clarity on offering costs and corporate governance.

Next Steps

  • File a further amendment to specifically state the effective date of the registration statement.
  • The SEC may determine the effective date of the registration statement.
  • File post-effective amendments to include required prospectuses, reflect fundamental changes, or disclose material changes to the plan of distribution.
  • Remove unsold securities from registration at the termination of the offering.

Key Dates

DateDescription
2019-02-25Independent Directors Contract with Dr. Hector Alila.
2019-03-13Independent Directors Contract with Timothy G. Glynn.
2019-06-21Jupiter Wellness, Inc.'s Form 1-A filed (referenced for Amended and Restated Certificate of Incorporation and Bylaws).
2019-07-29Independent Directors Contract with Christopher Melton.
2019-08-05Employment Agreement with Douglas O. McKinnon.
2019-08-19Jupiter Wellness, Inc.'s Form 1-A/A filed (referenced for Form of Regulation A Subscription Agreement).
2019-10-15Employment Agreement with Dr. Glynn Wilson.
2020-02-01Employment Agreement with Brian John.
2020-02-01Employment Agreement with Richard Miller.
2020-02-20Confidential Membership Interest Purchase Agreement with Magical Beasts LLC and Krista Whitley.
2020-02-20Sales Distribution Agreement with Ayako Holdings, Inc.
2020-06-17Company's Registration Statement filed (referenced for various exhibits).
2020-07-14Company's Registration Statement filed (referenced for various exhibits).
2020-11-05Distribution Agreement.
2020-11-09Company's Current Report on Form 8-K filed (referenced for Distribution Agreement).
2020-11-10Endorsement Agreement.
2020-11-19Company's Current Report on Form 8-K filed (referenced for Endorsement Agreement).
2020-11-30Share Exchange Agreement.
2020-12-03Company's Current Report on Form 8-K filed (referenced for Share Exchange Agreement).
2021-01-20Independent Directors Agreement.
2021-01-20Employment Agreement.
2021-01-25Omnibus Amendment.
2021-01-25First Amendment to Common Stock Option Agreement.
2021-01-26Company's Current Report on Form 8-K filed (referenced for Independent Directors Agreement).
2021-01-29Company's Current Report on Form 8-K filed (referenced for Omnibus Amendment and First Amendment to Common Stock Option Agreement).
2021-02-03Company's Current Report on Form 8-K filed (referenced for Employment Agreement).
2021-05-11Loan Agreement with Greentree Financial Group, Inc.
2021-05-13Company's Current Report on Form 8-K filed (referenced for Loan Agreement, Greentree Warrant, and Promissory Note).
2021-08-23Form 8-K filed (referenced for Amended and Restated Bylaws).
2022-04-20Loan Agreement, Promissory Note, and Warrant Agreement with Greentree Financial Group.
2022-04-22Company's Current Report on Form 8-K filed (referenced for Greentree Financial Group agreements).
2023-04-13Convertible Debenture Indenture between Yerba and Odyssey Trust Company.
2023-09-15Company's Current Report on Form 8-K filed (referenced for Greentree and L&H amendments).
2023-12-07Warrant Indenture between Yerba and Odyssey Trust Company.
2024-04-01Annual report on Form 10-K filed (referenced for Subsidiaries of the Registrant).
2024-04-04Form of Securities Purchase Agreement with Core 4 Capital Corp.
2024-06-27Form of Securities Purchase Agreement with Core 4 Capital Corp.
2024-08-30Form of Securities Purchase Agreement with Core 4 Capital Corp.
2024-09-06Form of Stock Option Agreement with Wall and Broad Capital, LLC.
2024-09-20Securities Purchase Agreement.
2024-09-24Company's Current Report on Form 8-K filed (referenced for Securities Purchase Agreement).
2024-12-18Advisory Agreement with Bristol Capital, LLC.
2024-12-31End of fiscal year for which M&K CPAS audited financial statements.
2025-01-17Form of Securities Purchase Agreement.
2025-02-04Employment Agreement with Danielle De Rosa.
2025-02-04Form of Securities Purchase Agreement.
2025-02-04Securities Purchase Agreement with Eleazar Holdings, LLC.
2025-02-10Current Report filed (referenced for Form of Warrant and Form of Securities Purchase Agreement).
2025-02-20Form of Securities Purchase Agreement.
2025-02-26Current Report filed (referenced for Form of Securities Purchase Agreement).
2025-03-13Form of Securities Purchase Agreement.
2025-03-19Current Report filed (referenced for Form of Securities Purchase Agreement).
2025-03-28Date of M&K CPAS report on financial statements for periods ending December 31, 2024 and 2023.
2025-04-10Form S-1 filed (referenced for Amendment to Settlement Agreement and Mutual Release).
2025-04-16Company's Registration Statement filed (referenced for various exhibits).
2025-04-23Stipulation of Settlement with 3i LP.
2025-05-02Exchange Agreement with Core 4 Capital Corp.
2025-05-07Form 8-K filed (referenced for Certificate of Designation of Series A Convertible Preferred Stock and Exchange Agreement).
2025-05-09Form of Securities Purchase Agreement.
2025-05-15Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-05-19Company's Registration Statement filed (referenced for various exhibits).
2025-05-27Form 8-K filed (referenced for Form of Settlement and Stipulation Agreement).
2025-06-04Form 8-K filed (referenced for Form of Amendment to Settlement Agreement and Stipulation).
2025-06-13Securities Purchase Agreement (referenced in Amendment No. 1 dated July 2, 2025).
2025-06-18Form of Securities Purchase Agreement.
2025-06-23Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-06-27Form 8-K filed (referenced for Convertible Debenture Indenture and Warrant Indenture).
2025-06-30Form of Securities Purchase Agreement.
2025-07-02Amendment No. 1 to Securities Purchase Agreement dated June 13, 2025.
2025-07-02Form of Exchange Agreement.
2025-07-02Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-07-03Form of Securities Purchase Agreement.
2025-07-09Form 8-K filed (referenced for Certificate of Designation of Series B Convertible Preferred Stock, Amendment No. 1, Form of Exchange Agreement, and Form of Securities Purchase Agreement).
2025-07-11Form of Securities Purchase Agreement.
2025-07-14Form of Securities Purchase Agreement.
2025-07-15Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-07-17Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-07-21Form of Securities Purchase Agreement.
2025-07-21Form of Placement Agency Agreement with Dominari Securities LLC.
2025-07-24Form 8-K filed (referenced for Form of Common Stock Purchase Warrant, Form of Placement Agent Warrant, Form of Securities Purchase Agreement, and Form of Placement Agency Agreement).
2025-07-25Release Agreement with Danielle De Rosa.
2025-08-05Form 8-K filed (referenced for Release Agreement).
2025-08-08Form of Securities Purchase Agreement.
2025-08-08Form of Revenue Sharing Agreement.
2025-08-14Form 8-K filed (referenced for Form of Securities Purchase Agreement and Form of Revenue Sharing Agreement).
2025-08-19Form 8-K filed (referenced for Amended and Restated Certificate of Designation of Series C Convertible Preferred Stock).
2025-08-25Form of Securities Purchase Agreement.
2025-08-29Form 8-K filed (referenced for Form of Securities Purchase Agreement).
2025-10-03Employment Agreement with Markita L. Russell.
2025-10-08Form 8-K filed (referenced for Employment Agreement).
2025-10-14Form 8-K filed (referenced for Certificate of Amendment of Certificate of Incorporation and Amendment to Amended and Restated Certificate of Designation of Series C Convertible Preferred Stock).
2025-11-07Form 8-K filed (referenced for Certificate of Amendment to Third Amended and Restated Certificate of Incorporation).
2025-11-07Form of Exchange Agreement with July 2025 Purchasers.
2025-11-07Form of Exchange Agreement with Fried LLC.
2025-11-07Form of Exchange Agreement with Trajan Holdings, LLC.
2026-01-28Filing date of Amendment No. 1 to Registration Statement on Form S-1.
2026-01-28Signature date of Jarrett Boon (CEO) and Markita L. Russel (CFO) for the registration statement.
2026-01-28Date of Consent of M&K CPAS, PLLC.

Recommendation

hold

This S-1/A filing is purely procedural, detailing estimated offering expenses and standard corporate indemnification policies. It does not contain any new financial results, operational updates, or strategic announcements that would warrant a change in investment recommendation. Investors should await the full prospectus or subsequent filings for substantive information.

Keywords

Bonk Inc., S-1/A, SEC Filing, Registration Statement, Public Offering, Indemnification, Corporate Governance, Offering Expenses, Securities Act, M&K CPAS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.